DiaSorin SpA (DiaSorin) is a medical diagnostics company that is engaged in the development, manufacturwing, and marketing of in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s immunodiagnostic and molecular diagnostics products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases, among others. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, Europe, the Middle East, Africa, and Asia. DiaSorin is headquartered in Saluggia, Piemonte, Italy.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company DiaSorin SpA
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
DiaSorin SpA Company Overview
DiaSorin SpA Company Snapshot
DiaSorin SpA Pipeline Products and Ongoing Clinical Trials Overview
DiaSorin SpA – Pipeline Analysis Overview
Business Description
DiaSorin SpA - Key Facts
DiaSorin SpA - Major Products and Services
DiaSorin SpA Pipeline Products by Development Stage
DiaSorin SpA Ongoing Clinical Trials by Trial Status
Simplexa Enterovirus Direct - Product Description 0
Simplexa MRSA Direct - Product Status
Simplexa MRSA Direct - Product Description
Verigene I Acute Dx - COVID-19 - Product Status
Verigene I Acute Dx - COVID-19 - Product Description
VERIGENE I SARS-CoV-2 - Product Status
VERIGENE I SARS-CoV-2 - Product Description
Verigene II Acute Dx - COVID-19 - Product Status
Verigene II Acute Dx - COVID-19 - Product Description
Verigene II Gastrointestinal Flex Assay - Product Status
Verigene II Gastrointestinal Flex Assay - Product Description
Verigene II Gastrointestinal Flex Assay - A Clinical Study of Gastrointestinal (GI) Assay on VERIGENE II System in the Detection of Gastrointestinal Infections
Verigene II Respiratory Flex Assay - Product Status
Verigene II Respiratory Flex Assay - Product Description
VERIGENE II SARS-CoV-2 - Product Status
VERIGENE II SARS-CoV-2 - Product Description
Verigene II Syndromic Dx - COVID-19 - Product Status 9
Verigene II Syndromic Dx - COVID-19 - Product Description 9
Verigene II System - Product Status 0
Verigene II System - Product Description 0
Verigene II System - Blood Culture ID Assay - Product Status 1
Verigene II System - Blood Culture ID Assay - Product Description 1
Verigene II System - Meningitis Panel - Product Status
Verigene II System - Meningitis Panel - Product Description
Verigene II System - Syndromic Assay - Product Status
Verigene II System - Syndromic Assay - Product Description
xMAP-Powered Assay - Breast Cancer - Product Status
xMAP-Powered Assay - Breast Cancer - Product Description
DiaSorin SpA, Key Employees
DiaSorin SpA, Key Employee Biographies
DiaSorin SpA, Other Locations
DiaSorin SpA, Subsidiaries
Glossary
List of Figures
DiaSorin SpA Pipeline Products by Equipment Type
DiaSorin SpA Pipeline Products by Development Stage
DiaSorin SpA Ongoing Clinical Trials by Trial Status